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Toward the Total Synthesis of 7-Deoxypancratistatin 
 
Introduction 
 Efficient carbon-carbon bond forming reactions have long been a goal of 
synthetic organic chemists.  Among the most prominent of the carbon-carbon bond 
forming reactions are the Stille and Suzuki 1-4.  Since their development these cross-
coupling reactions have been widely used in the construction of highly functionalized 
and structurally-complex molecules5-7.   
The Stille coupling is a Pd-mediated reaction in which a carbon-carbon bond 
is formed between the aryl group of an aryl halide 1 and an aryl group from the 
corresponding stannane to afford a biaryl product 2 8-12 (Scheme 1).  The wide utility 
of this reaction has long been hampered by the toxicity of stannanes and the 
inherent difficulty in removing tin by-products from the reaction mixtures.  Closely 
related to the Stille reaction is the Suzuki coupling.  An analogous carbon-carbon 
bond construction is feasible with this methodology, however, in the Suzuki method a 
carbon-carbon bond is formed between the aryl group of the aryl halide 1 and the 
aryl group of the boronic acid (or borate ester)13.  Again the product is 2.  Drawbacks 
to the Suzuki coupling surround the use of the boronic acids which are often difficult 
to purify.  Additionally, boronic acids are acid sensitive – negating their introduction 
early in the synthesis in preparation for a late stage coupling sequence.   
The difficulties in aryl-aryl coupling have prompted chemists to persevere in 
the advancement of innovative methodologies.  In the early 1990’s the DeShong 
group began investigating an aryl-aryl coupling methodology complementary to the 
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Stille and Suzuki couplings.  In this new methodology aryl-aryl carbon bonds are 
formed between the same aryl halide 1 and an aryl siloxane in the presence of both 
palladium (0) and a hypercoordinate siloxane moiety (Scheme 1)14-17.  Product 2 is 
formed.  The advantages to the siloxane mediated cross coupling are many.  Silicon 
based arylating agents are easily prepared (by several methods)14,16,18,19 and are 
easily purified (distillation or chromatography) compared with their boronic acid 
counterparts.  Siloxanes are substantially less toxic than their organotin counterparts 
and maintain a wide functional group tolerance.   
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 The use of hypercoordinate siloxanes has since been extended to facilitate 
the transfer an aryl group from a siloxane to an allylic system such as 3 to 
catalytically prepare compounds such as 4 20-25.  (Scheme 2)  Catalytic allylic 
alkylations are also well known in the literature26-34.  Generally, allylic alkylations  
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are organized into two varieties:  those using “soft nucleophiles”and those using 
“hard nucleophiles”4,29,35.  The terms “hard” and “soft” nucleophile are not well 
defined.  Generally, soft nucleophiles are described as those nucleophiles whose 
conjugate base has a pKa <25, e.g. diethylmalonate.  Comparatively, hard 
nucleophiles are defined as those nucleophiles whose pka is >25.  Examples of hard 
nucleophiles include Grignard reagents and siloxanes.   
Soft and hard nucleophiles exhibit different mechanistic reactivity and 
different reaction stereoselectivity (Scheme 3).  Consider the stereoselectivity first.  
Allylic alkylation involving soft nucleophiles occurs with overall retention of 
stereochemistry with respect to the original stereochemistry, i.e. in the starting 
material 3 the benzoate group in the S configuration; in the product, alkylation with 
diethylmalonate occurs on the bottom face of the system to afford 5.  This is an 
overall retention of stereochemical configuration.  The opposite is observed with hard 
nucleophiles.  The stereochemistry of the starting benzoate is S (3);  
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arylation, however, occurs on the top face of the allyl system resulting in overall 
inversion of stereochemistry (4). 
The origin of the stereochemical differences for soft and hard nucleophiles 
can be explained by considering their respective mechanisms 4,35.  Consider first, the 
mechanism of allylic alkylation with soft nucleophiles (Scheme 4).   Palladium (0) 
complexes the sterically less demanding face of olefin 3 forming the palladium 
complexed intermediate 6.  Palladium oxidatively adds to the pi-allyl system  
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displacing the benzoate (7).  In the presence the nucleophile, the conjugate base of 
diethylmalonate (soft nucleophile), the nucleophile adds to the less hindered bottom 
face of the pi-allyl forming intermediate 8.  Decomplexation of the palladium from the 
olefin affords the allylic alkylation product (5) and regenerates palladium (0).  The 
displacement of the benzoate by palladium from the opposite face of the leaving 
group (inversion), followed by displacement of the palladium by diethylmalonate 
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anion from the opposite face of the metal (inversion) results in overall retention of 
stereochemistry at the reaction center.  
The mechanism of allylic alkylation is different when a hard nucleophile is 
used.  Palladium (0) complexes the sterically less demanding face of olefin 3 forming  
 
Scheme 5. 
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the palladium complexed intermediate 6.  Palladium oxidatively adds to the pi-allyl 
system displacing the benzoate (7).   In the presence of a hypercoordinate siloxane 
9, the phenyl ring is transmetallated to the palladium affording the intermediate 10.  
Subsequently, the palladium reductively transfers the phenyl ring to the pi-allyl 
system; this occurs from the same face occupied by the palladium, the top face (11).  
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Upon decomplexation of palladium from the olefin, the allylic arylation product 4 is 
formed and palladium (0) is regenerated.  The displacement of the benzoate by 
palladium from the opposite face of the leaving group (inversion), followed reductive 
elimination of the phenyl ring by palladium on the same face of the metal center 
(retention) results in overall inversion of stereochemistry at the reaction center. 
 The goal of all synthetic methodology is practical utility.  In an effort to 
validate the utility of the allylic arylation methodology developed in the DeShong lab, 
the synthesis of 7-deoxypancratistatin was targeted.  In addition to being an 
appropriate target for the application of the said chemistry, 7-deoxypancratistatin 
exhibits interesting biological activity. 
In the early 1970’s, the National Cancer Institutes exploratory plant screening 
program identified potent anti-cancer activity from extracts of Amaryllidacea 
alkaloids36.  Extracts from one species in particular, the Hawaiian Pancratium 
littorale, showed remarkable potential in early screening assays.  Upon isolation and 
analysis of the active components, it was found that pancratistatin 16, was 
responsible for the observed biological activity.36,37  Subsequently, 7-
deoxypancratistatin 22 was isolated; this analogue was found to possess improved 
biological activity with reduced toxicity38.   
Studies have revealed the cancer fighting mechanism of 7-
deoxypancratistatin to be involved with the inhibition of ribosomal peptidyl 
transferase, i.e. inhibiting protein synthesis at the step of peptide bond formation39-41.  
More detailed investigations into improving the activity of the molecule and 
decreasing its in vivo toxicity are limited by its natural abundance.  Therefore, the 
need for an efficient route to 22 is needed.   
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The syntheses of pancratistatin, 7-deoxypancratistatin, and its analogues 
have attracted the interest of synthetic chemists due to both their structural 
complexity as well as interesting biological activity.  Greater than 10 groups are 
pursuing the synthesis of pancratistatin and its analogues; most seek to discover a 
general approach to the skeleton of these alkaloids.   
In 1992, Heathcock proposed a general methodology to prepare the basic 
ABC framework of the this class of compounds.42  His goal was a low cost route to 
multi-gram quantities of Amaryllidaceae alkaloids for use in clinical trial 
investigations.   
 The previously prepared amide 12 was orthometallated in the presence of 
sec-BuLi, trapped with electrophilic 1-nitrocyclohexene, and after acidic workup 
afforded a mixture of the cis and trans aryl nitrocyclohexanes products 13.   
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Equilibration of the cis/trans mixture with Et3N afforded the more stable 1,2-trans 
substituted system 14.  The nitro group was reduced to amine in the presence of 
NiCl2 and upon addition of sec-BuLi the amine underwent an intramolecular 
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cyclization to afford the lactam.  Deprotection of the TBDMS ether with acid gave the 
core ABC ring structure of pancratistatin 15.   
Trost reported the first asymmetric total synthesis of (+)-pancratistatin.43 The 
route involved the classic desymmetrization strategy employed by Trost in his own 
allylic alkylation methodology1,29,32,34,43-45 (Scheme 7).  Retrosynthetically, (+)-
pancratistatin (16) was prepared from isocyanate 17.  Compound 17 was treated 
with tert-butyl lithium to effect lithium halogen exchange.  The aryl lithium species, 
generated in situ underwent an intramolecular addition onto the isocyanate affording 
the intact A-B-C ring structure.  Compound 17 was prepared from 18.  Electrophilic 
aromatic bromination followed by conversion of the azide to the isocyanate afforded 
17.  Compound 18, in turn, was prepared utilizing organocuprate chemistry to effect 
the coupling between 19 and 20.  The enantiomerically pure allyl azide 20 was 
prepared from the dimethylcarbonate 21 upon desymmetrization with a chiral 
palladium complex and a nitrogen nucleophile (85%, ee >95%).   
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The Mehta group is currently working on the total synthesis of pancratistatin 
and more specifically, on a general route to approach the phenanthridone alkaloids 
family.46  In 1998, Mehta published his preliminary work towards this goal.  Below in 
Scheme 8 is the retrosynthesis.   
 Retrosynthetically, 7-deoxypancratistatin 22, would be available from the 
highly functionalized precursor 23.  Mehta envisioned 23 being easily prepared from 
dihydroxy compound 25.  Compound 24 was prepared in two steps (a. OsO4, NMO 
b. Amberlyst-15, MeOH, Ac2O, Py) from the corresponding olefin 25.  Allylic alcohol 
25 was prepared via Baeyer-Villiger oxidation of the bicyclic ketone 26.  Compound 
26, in turn, is prepared from the readily available endo-phenyl-7-norbornenone-
dimethyl acetal 27. 
 The last report in the literature from the Mehta group detailing their progress 
towards the pancratistatin family was in 1998.  At the time, the group had completed 
the highly functionalized core containing the 6 contiguous stereogenic centers of the 
C ring.  However, to date, the elaboration of the system to complete the synthesis 
has not yet been realized.   
 Despite not yet having completed the total synthesis of pancratistatin, the 
approach developed by Mehta has the potential to construct pancratistatin in an 
asymmetric fashion, but also maintains the inherent ability to easily access other 
highly functionalized cyclohexanoid systems.  The generality of this methodology is 
easily amenable to the synthesis of closely related analogues for structure activity 
analysis.   
 In 1993, Martin reported a formal synthesis of (+)-pancratistatin 16 (via the 
synthesis of (+)-lycoricidine 28)(Scheme 9).47  Analyzing Martin’s disconnection 
approach, (+)-lycoricidine 28 and hence (+)-pancratistatin 16 would be available from 
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Scheme 8. 
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the intramolecular Heck coupling of aryl bromide  with double bond of the C ring 29.  
The aryl amide 29 was easily constructed from the nucleophilic acyl substitution 
reaction between aryl acid chloride 30 and allylic amine 31.  Compound 32 was 
prepared from the hetero Diels - Alder reaction of diene 33 and the in situ generated 
acyl nitroso compound 34.  
 The first total synthesis of (+)-pancratistatin was reported in 1989 by Samuel 
Danishefsky (Scheme 10).48  Retrosynthetically, the group envisioned the 
preparation of (+)-pancratistatin 16 from lactone 35.  Saponification of the lactone 35 
with K2CO3 presumably through the amino-carboxylic acid intermediate followed by 
treatment with treatment with DCC afforded the pancratistatin lactam.  Oxidation of 
carbons 3 and 4 of 36 with catalytic osmium tetraoxide / NMO afforded the desired 
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amino triol 35.  The existing 1,4-amino alcohol directed the osmylation at the β-face 
of the molecule.  The installation of the C-3 alcohol of 38 and migration of the double 
bond was effected by the Overman rearrangement; the C-3 alcohol was converted to 
the corresponding imidate (NaH, trichloroacetonitrile).  The C-3 imidate  (neat) 
rearranged under high vacuum and pyrolysis (100 °C – 105 °C) conditions to afford 
37.  Compound 38 was prepared from 37 in 6 steps through a series of 
“carbohydrate reminiscent” functional group manipulations required for achieving the 
desired stereochemistry on the highly oxygenated C ring.  Halolactonization 
((Bu2Sn)2O, I2) of compound 39 afforded compound 38.  Compound 39 is prepared 
from the orthometallation of 40 followed by a DMF quench to afford the 
corresponding aldehyde.  The aldehyde was elaborated to a 1,3 butadiene moiety; 
this diene underwent a Diels Alder reaction with a known masked alkynyl dienophile 
to generate the 1,4-cyclohexadiene substrate 39.  Compound 40 is known from the 
literature.   
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 In the late 1990’s, John Hasteltine published the completion of a formal total 
synthesis of (+)-pancratistatin.49,50  The key step in the route was an electrophilic 
aromatic substitution reaction to construct the B – ring.  Depicted below is the 
retrosynthesis (Scheme 11). 
 (+)–Pancratistatin 16 would be available in a formal synthesis from the di-
deoxy compound 41 (An intermediate in the Danishefsky synthesis).  Elaboration 
from 41 to 16 required 6 additional steps).48  Compound 41 was prepared from the 
intramolecular electrophilic aromatic substitution reaction between the functionalized 
arene of the A ring with the olefin of 42.  Compound 42 was constructed via the SN2 
displacement by the alcoholate of 44 with benzylbromide 43.   
 Several problems make the Haseltine synthesis inappropriate for large-scale 
(+)-pancratistatin production.  First and foremost, the synthesis is long; the longest 
linear sequence contains 27 steps.  Many transformations including those towards 
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Scheme 11. 
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the end of the synthesis suffer from low yields.  The key electrophilic aromatic 
substitution step used to construct the ABC ring system is intolerant of structure 
diversity; for all variants, save the one employed, an undesired rearrangement was 
observed.  Lastly, as is the case with most attempts towards pancratistatin, 
researchers were plagued with poor atom economy as excessive protections and 
deprotections were required to differentiate the C ring hydroxyls and achieve the 
requisite stereochemistry.   
 The Hudlicky group has been prolific in the development of a rational 
synthesis of (+)-pancratistatin and (+)-7-deoxypancratistatin. In addition, the 
syntheses of several analogues have elucidated interesting structural activity 
features of this class of molecules51,52.  Total syntheses of narciclasine 45, ent-7-
deoxypancratistatin 46, 10b-epi-deoxypancratistatin 47 have been reported as well 
as the synthesis of several abridged systems.51  (Figure 1).   
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Figure 1.  Analogues of 7-Deoxypancratistatin. 
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Over a period of 10 years the group has published several syntheses of these 
biologically relevant compounds, each time addressing and improving upon previous 
synthetic hurdles.   
The Hudlicky group published syntheses of both (+)-pancratistatin and (+)-7-
deoxypancratistatin in 1995.53,54  The retrosynthesis for the pancratistatin synthesis 
is shown below (Scheme 12).  Pancratistatin 16 was prepared in one step from 48.  
Under conditions which effect the opening of the epoxide, the BOC group was 
cleaved; additionally under these reaction conditions, the free amine condensed 
upon the methyl ester thereby affording the desired lactam of 16.  The carbon-carbon 
bond fusing ring A with ring B was effected by preparing the organocuprate of 50 (1. 
s-BuLi, TMEDA 2. CuCN) and coupling it with the tosylaziridine 49.  The aziridine 49 
was prepared in 3 steps from bromodiol 51.  Compound 51 was prepared as the 
featured intermediate from 52, utilizing enzymatic oxidation with Pseudomonas 
putida.   
 Although the first generation Hudlicky synthesis was fairly concise (requiring 
only 13 steps) several of the steps would be problematic in the elaboration of this 
synthesis to large-scale preparation of pancratistatin.  The copper mediate coupling 
of 50 and 49 was prone to epimerization at carbon 10b.  Furthermore, the late 
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installation of the intact ABC ring system made selective β-epoxidation difficult as a 
result of atropisomerism at the AC ring.   
Scheme 12. 
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In an effort to address some of the synthetic “pitfalls” encountered in their first 
generation synthesis of (+)-pancratistatin, Hudlicky soon thereafter reported a 
revised synthesis54.  The group initially sought to address two key problems in the 
maiden synthesis:  The problems addressed were the detosylation of the aziridine 
followed by its reprotection as the carbamate and secondly the issues associated 
with atropisomerism about the AC ring system.  In practice, however, this second 
generation synthesis only addressed the latter problem. (Scheme 13).  The second-
generation synthesis circumvented problems surrounding the hindered rotation about 
the AC ring by a few simple changes.  Again, retrosynthetically, (+)-pancratistatin 16 
was prepared from the Bischler-Napieralski cyclization of 53.  Intermediate 53 was 
available from the copper-mediated coupling of 49 and 54; the optimized yield for this 
key carbon-carbon bond forming reaction was 32%.  The low yield was attributed to 
either the instability of the organolithium species from which 54 was prepared or the 
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instability of the cuprate, itself.  (The cuprate of 50 in the previous synthesis was 
believed to possess enhanced stability due to the presence of the amide at the ipso 
position.)  The tosyl aziridine 49 was prepared as in the first synthesis, featuring the 
enzymatic oxidation of a substituted benzene 52 affording diol 51.     
Scheme 13. 
A B
O
O NH
O
OH
OHHO
OH
OH
C
Br
52
OH
OH
Br
51
O
O
H
TsN
49
O
O
OTBS
Cu(CN)Li2
+
54
O
O
HN
OH
OH
OBn
CO2Me
O
16 53
10b
2
 
One key hurdle was overcome in the Hudlicky synthesis: the problem of 
atropisomerism was circumvented by avoiding a coupling reaction in connecting the 
AC ring system in which there were 2 ortho substituents as in the previous synthesis 
(Scheme 12 and Scheme 13, Figure 48 vs. 53).  However, a snag in the synthesis 
emerged – a drastic reduction in yield was observed in the coupling reaction.  
A third generation approach to (+)-pancratistatin and (+)-7-
deoxypancratistatin was published in 199655. The retrosynthesis for the former is 
given below in Scheme 14.  The retrosynthesis for (+)-7-deoxypancratistatin can be 
found in Scheme 15. 
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Scheme 14. 
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Again, retrosynthetically the Hudlicky group prepared the enantiomerically 
pure pancratistatin 16 from intermediate 48 upon the BOC deprotection of the C ring 
nitrogen followed by cyclization onto the ester to afford the B ring β-lactam and 
simultaneous nucleophilic epoxide opening.  Ester 48 was prepared from the 
corresponding aldehyde 55 which was in turn was prepared from the corresponding 
amide 56.  The AC bond was accomplished via the copper mediated coupling of aryl 
cuprate 57 with vinyl aziridine 58.   
The Hudlicky group made several insights during this synthesis.  The first 
insight gathered, circumvented some of the stereochemical problems which plagued 
the earlier syntheses.  First, although compound 48 exists in two atropisomeric 
forms, the face of epoxidation is immaterial.  Ring opening is degenerate and should 
give the same product 61 for both the α- (59) and the β-epoxide (60) (Figure 2). 
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Figure 2.  Degenerate Epoxide Ring Opening. 
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The (+)-7-deoxypancratistatin retrosynthesis follows (Scheme 15).  It applies 
much of the knowledge attained from the (+)-pancratistatin synthesis. 
Scheme 15. 
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7-Deoxypancratistatin was derived from epoxide 62.  Nucleophilic ring 
opening of epoxide 62 followed by cyclization under Banwell’s Bischler-Napieralski 
conditions afforded the target molecule 22.  The epoxide 62 was prepared from the 
corresponding olefin 63.  The methylcarbamate of 63 was prepared from the 
corresponding tosyl amide 49.  The intact AC ring system was prepared as 
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previously described via the copper-mediated coupling of cuprate 65 with 
tosylaziridine 49.   
Within months of the Hudlicky group publishing their first generation synthesis 
of (+)–7-deoxypancratistatin, the Keck group published their first total synthesis.56  
Since the initial report, two subsequent improvements have been reported.57,58  The 
retrosynthesis below details the Keck approach, which features a stereo-selective 
radical cyclization to effect the C ring.   
 Retrosynthetically, (+) -7-deoxypancratistatin 22 was prepared from the 6-exo 
radical cyclization of the benzylic radical onto the oxime ether 66 followed by the 
Danishefsky “Overman rearrangement approach”.  Addition of the aryl Grignard of 67 
onto oxime 68 allowed the construction of “radical cyclization precursor” 66.  
Compound 68 was prepared from 69 upon conversion of the existing aldehyde to the 
oxime ether, oxidation of the primary alcohol to the aldehyde and the differential 
protection of the C1-4 hydroxyls.  Compound 69 is easily available in 
enantiomerically pure form from the chiral pool.  DIBAL reduction of D-Gulonolactone 
70 affords 69 in excellent yield.   
 The stereoselectivity in the radical cyclization can be explained by 
considering the relative energy of the radical intermediates (Scheme 17).  The two 
possible reactive conformers are depicted below:  intermediate 71 depicts the fusion 
of the BC ring in a cis fashion; intermediate 72 depicts the fusion of the BC ring in a 
trans fashion.  It is well known in decalin systems that the cis fused system is more 
stable than the corresponding trans fused system as the conformational flexibility 
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Scheme 16. 
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contributes to the thermodynamic stability, hence the product observed possesses a 
cis fusion at the BC ring juncture.   
 The Keck synthesis was successful in proving the viability of the radical 
cyclization approach towards the construction of highly functionalized molecules.  
The synthesis was significantly shorter than many of the earlier attempts ((+) – 7-
deoxypancratistatin was prepared in 21 steps).  Ultimately, the weakness of the 
synthesis was two-fold.  The approach lacked convergence as the aryl portion of the 
molecular was coupled with the aliphatic moiety very early in the synthesis.  
Secondly, the key step, the radical cyclization was capricious; control of the 
stereochemistry at the BC juncture was problematic as was the competitive reduction 
of the B ring lactone.   
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The goal of my project was to develop a concise and general approach to the 
Amaryllidaceae alkaloids using the allylic coupling reaction developed in our lab.  To 
exemplify the feasibility of this approach, 7-deoxpancratistatin was targeted.  As 
previously described, this molecule is a highly sought synthetic target due to both its 
structural complexity and interesting biological activity.  Furthermore, previous 
syntheses of this compound lacked the necessary efficiency that would allow a full-
scale investigation of this compound as a drug candidate. 
Prior to the undertaking of this formidable synthetic target, 7-
deoxypancratistatin, a simplified model system 75 was completed to assess the 
feasibility of the key allylic arylation reaction.  The retrosynthetic approach mirrors 
that used in the 7-deoxypancratistatin synthesis.  In terms of functionality, the 
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model chosen lacked only the C3, C4 cis hydroxyl groups.  The model compound 
was prepared from the allylic arylation reaction of siloxane 76 with allylic carbonate 
77 in the presence of palladium (0)24.   The reaction predictably provided a 1:1 
mixture of regioisomers; this lack of selectivity can be explained by analyzing the pi-
allyl intermediate.   
 The mechanism of this coupling reaction is analogous to that described 
previously in Scheme 5.  For simplicity, palladium-olefin coordination was omitted for 
clarity.  The arylation group, siloxane 76, was simplified to ArSi(OEt)3 below in 
Scheme 19.  Upon coordination of Pd(0) to the olefin of 77, Pd(0) displaces the 
carbonate group from the less sterically encumbered top face of the molecule.  The 
pi-allyl intermediate 78 is formed.  In the presence of aryl siloxane (76) and a fluoride 
source, the aryl group is transferred from silicon to palladium to form species 79.  
Reductive elimination occurs with equal proclivity to provide the 1,2-allylic arylation 
isomer 80a and the 1,4-allylic arylation isomer 80b in a 1:1 ratio.  Selectivity is not 
observed in this reductive elimination as there are no substituents in the 5 or 6 
positions on the top face of the cyclohexyl system to bias the elimination.  
Correspondingly, the carbamate moiety cannot influence the selectivity of this 
reductive elimination as the chemistry is occurring on the top face of the molecule 
and the carbamate resides on the bottom face. 
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 The success of this allylic arylation reaction had demonstrated several details 
about the allylic arylation reaction.  The coupling occurred, as predicted, without 
selectivity.  This result validated our confidence in both the application of this 
methodology to 7-deoxypancratistatin and our understanding of the mechanism.   
At this point the project was divided into two separate pieces.  The first target 
was the completion of the synthesis for the model system, i.e. carrying coupling 
product through the remainder of the synthesis.  Model compound 77 was 
synthetically much simpler to prepare and its elaboration would facilitate the total 
synthesis of 7-deoxypancratistatin.  The second project was the total synthesis of 
(+)-7-deoxypancratistatin.  The latter was the focus of my thesis research.
 
 
Results and Discussion 
 The approach to (+)-7-deoxypancratistatin is described retrosynthetically in 
Scheme 20.  Preparation of 7-deoxypancratistatin 22 is readily feasible from olefin 81 
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upon epoxidation and subsequent ring opening55,59,60.  Olefin 81 would be prepared 
from compound 82, employing Bischler-Napieralski chemistry61,62.  The key step in 
the sequence is the coupling of aryl siloxane 78 with allylic carbonate 83.  The allylic 
carbonate of 83 was prepared from the Diels-Alder reaction of diene 85 with nitroso 
compound 8463-70.   
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 This synthetic approach has many potential advantages over the previously 
reported methods.  First, the route described herein is towards racemic 7-
deoxypancratistatin; this route can be easily adapted, using well-known and well-
precedented chemistry to the synthesis of the enantiomerically pure target.71  
Secondly, the key synthetic intermediate (diene 85) was prepared in four steps from 
commercially available materials.  From a process chemistry point-of-view, 
elimination of these four steps would be facile.  This diene (and many related 
analogues) are available from the enzymatic oxidation of benzene (and its 
derivatives) to afford, in one step, the desired diene (85) in >99% yield72-75.  
Biooxidations of this type are well studied and are now widely used organic 
synthons.  These compounds are routinely prepared on the hundred-kilogram scale.  
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A third advantage to this synthetic strategy is the high regioselectivity expected from 
the key coupling reaction.  This transformation which accomplishes the key carbon-
carbon bond between the A and C rings has been a hurdle in previous syntheses.  
(Recall the Hudlicky synthesis; Hudlicky uses a higher order cuprate coupling and 
accomplishes the transformation in a 30 % optimized yield.)  Lastly, the product of 
the allylic arylation coupling reaction will accomplish a formal synthesis of the target 
in 4 steps from commercially available materials.  A total synthesis should be 
possible in 3 additional steps (Bischler- Napieralski cyclization, epoxidation/ring 
opening, and global deprotection).   The shortest synthesis of (+)-pancratistatin to-
date is 15 steps.   
 Our first generation synthesis of allylic carbonate 83 is given below in 
Scheme 21.   The starting material for this synthesis was commercially available 1,4-
cyclohexadiene 86.  Upon bromination at –78 °C dibromoalkene 87 can be prepared 
in 82% yield76.  (The formation of the dibrominated product in preference to the 
tetrabrominated product is attributed to the insolubility of the dibrominated product at 
the reaction temperature.)  Dihydroxylation is accomplished using catalytic osmium 
tetraoxide and stoichiometric N-methylmorpholine N-oxide as the sacrificial oxidant 
(88).  Protection of the diol as the isopropylidene is easily obtained with 2,2-
dimethoxypropane and a catalytic amount of p-toluenesulfonic acid (89)77.  The 
dehydrobromination of 89 affords the requisite diene 8576.  Diene 85 underwent a 
hetero Diels-Alder cyclization with the α-chloronitroso compound 8478,79 yielding 
9071,80 as the hydrochloride salt.  Subsequent reduction of the N-O bond using Al-Hg 
amalgam afforded allylic alcohol 91 without incident81.  Protection of the amine and 
alcohol as the ethyl carbamate (92) and ethyl carbonate (83), respectively, affords 
the desired allylic coupling partner. 
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 During the course of the synthesis, however, it was found that the route 
utilizing the α-chloro nitroso Diels-Alder reaction was cumbersome.  Most 
significantly, the reaction set-up for the Diels-Alder reaction was lengthy, requiring 
several hours of preparation; additionally, the reaction yields were low, 
irreproducible, and reactions times required greater than 5 days at 0 °C.  The 
separate steps required to protect the alcohol and the amine decreased the elegancy 
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of the synthesis; this was another area that required improvement.  Finally, as a 
matter of compound manipulation, i.e. chromatographic purification and the 
monitoring of the reaction’s progress was difficult due to the lack of UV activity of this 
series of compounds.   
 In an attempt to address some of these synthetic hurdles, the synthesis was 
rerouted.  Scheme 22 depicts the modified course.  All of the impediments of the 
maiden synthesis were addressed in this second generation route.  First and most 
importantly, the Diels-Alder sequence was much improved; the α-chloro nitroso 
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dienophile was replaced with an acyl nitroso dienophile 9382.  The acyl nitroso 
dienophile much easier to handle when compared with the chloronitroso analogue, 
i.e. the reaction set-up was simplified, the yield was much improved, and the reaction 
time was decreased.  Additionally, utilizing nitroso compound 93, the number of 
steps in the overall synthesis was reduced as protection of the amine was 
accomplished during the cycloaddition.  Lastly, the handling and preparation of the 
acyl nitroso was much simpler than the analogous α-chloronitroso compound.   
 With Diels-Alder adduct 94 in hand, the N-O reduction sequence was 
addressed.  Previous studies in the DeShong laboratory revealed that reduction of 
an acylated nitrogen of an N-O bond is more resistant to reduction that a free 
amine24.  In this light, a literature search detailed a procedure for effecting this 
transformation utilizing a catalytic amount of Mo(CO)6 in the presence of a 
stoichiometric amount of NaBH4.83.  The reaction proceeded without incident to 
provide the desired allylic alcohol 95 and the nitrogen protected as a carbamate.  
Treatment of the allylic alcohol with ethylchloroformate afforded the desired coupling 
partner 96 in good yield.   
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 The siloxane coupling partner was easily prepared from commercially 
available aryl bromide 97 (Scheme 23).  Treatment of bromide with magnesium (0) 
generated the desired Grignard reagent which was quenched with 
tetraethylorthosilicate.  The desired product 78 was easily obtained via distillation.  
The modest reaction yield for this transformation is attributed to the instability of the 
ensuing Grignard species as well as the lack of electrophilicity of the 
tetraethylorthosilicate.   
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 Once completing the syntheses for the obligatory allylic carbonate 96 and aryl 
siloxane 78, the two were reacted under standard allylic arylation conditions 
(Pd2dba3, TBAF, THF, 50 °C, Scheme 24).  Analysis of the reaction mixture has 
shown that all starting material is consumed during the course of the reaction, 
however, the desired coupling product 98 was not observed.  Recall, however, that 
the coupling of aryl siloxane 78 with the simplified allylic carbonate system 77 
resulted in efficient coupling (Scheme 24) as 83 and 77 differ only in the presence 
of the cis diol moiety at the 3 and 4 positions on the C ring, it can be rationalized that 
this moiety is responsible for sterically impeding the desired coupling.  The 
modifications to the synthesis were directed at correcting this problem.   
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Figure 3.  Sterics Involved with pi-Allyl Formation. 
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 In addition to reworking the key step of the synthesis, the chemical literature 
was also explored for insight.  In a 1998 review article Trost described the application 
of allylic alkylation methodology to a variety of total syntheses.29  The catalyst of 
choice for most of these allylic alkylations was Pd(dba)2, however, the catalyst used 
for a substrate reminiscent of 83 was allyl palladium chloride dimer29.  Although no 
comment was made for use of this catalyst, it can be surmised that the typical 
catalyst choice (Pd(dba)2) was ineffective and a more “active” catalyst choice should 
be considered.   
 Supplied with the knowledge that our typical catalyst choice may have been 
ineffective in achieving our desired allylic arylation the following two control 
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experiments were performed (Scheme 25).  First, allylic carbonate 96 was reacted 
under identical reactions conditions save for the use of allyl palladium chloride dimer 
in place of Pd(dba)3.  In the presence of this presumably more activated catalyst 
system, an unexpected aryl ether 102 was isolated from the reaction mixture24.  
Additionally, as a control experiment, allyl carbonate 96 was subjected to allylic 
alkylation conditions and the nucleophile was varied.  In the presence of the soft 
nucleophile, the anion of diethylmalonate, coupling was observed and the expected 
mixture of products 103 and 104 were isolated. 
 This set of experiments has provided a number of interesting insights.  
Consider the siloxane mediated allylic arylation.  First, merely changing the catalyst 
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from Pd(dba)3 to allyl palladium chloride dimer afforded an arylation product; albeit 
an undesired aryl ether.  The formation of such a product has not been described in 
the literature.  There exists several possibilities for the origin of oxygen incorporation.  
The oxygen may be derived from the TBAF solution which was used as the fluoride 
source; all commercially available TBAF solutions such as that used during the 
course of these experiments contains 5% water.  A second possibility is that the 
ether oxygen is derived from the carbonate following its rearrangement and 
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subsequent hydrolysis (Scheme 26).  This phenomenon is well-precedented in 
carbohydrate and even allylic allylation chemistry; acetates are known to frequently 
migrate from hydroxyl to hydroxyl.  In the presence of palladium, chiral allylic acetate 
105 undergoes desymmetrization upon forming pi-allyl 10684.  Eventually, the racemic 
product 107 is observed.  The same explanation could explain the migration of the 
allylic carbonate of 83 through the palladium pi-allyl 108 to afford the regioisomeric 
product 109.  The allylic alcohol formed upon subsequent hydrolysis of carbonate 
109 could potentially be responsible for the formation of aryl ether 102.  Despite 
these hypotheses a clear arrow-pushing mechanism to explain the formation of aryl 
ether 102 from 83 has remained elusive. 
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Unfortunately, neither of these mechanistic pathways have been validated or 
eliminated to date.  On the other hand, consider the stereochemical implications of 
each scenario.  The ether product has been determined to be cis with respect to the 
carbamate moiety by X-ray crystallographic analysis.  It is arguable that incorporation 
of the ether oxygen via water (TBAF) could occur in either a cis or a trans fashion, 
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but only the cis product is observed.  Should the oxygen incorporation result from 
carbonate hydrolysis and subsequent rearrangement, the oxygen should inherently 
be cis relative to the carbamate.  In either case, a definitive answer has not yet been 
found. 
The success of the allylic alkylation with the soft nucleophile, diethyl 
malonate, affording 103 and 104 was a result that provided much insight into the 
problems with the key coupling step.  This experiment has shown that all the steps 
prior to the allylic alkylation occurred without incident, i.e. oxidative addition and 
allylic alkylation.  As described previously in the introduction, hard and soft 
nucleophiles react in allylic arylation reactions via an unique mechanistic pathways.  
Mechanistically, hard nucleophiles undergo a transmetallation step while soft 
nucleophiles do not.  Additionally, the reductive elimination pathway is different.  
Recall, in the presence of a hard nucleophile reductive elimination occurs from the 
same face as the metal center.  In the case of a soft nucleophile, the reductive 
elimination occurs on the face opposite the metal center.  One of two conclusions 
can be drawn from this experiment.  The first, during the course of allylic arylation 
reaction (Scheme 24), the transmetallation step was not feasible.  The second 
possibility is that reductive elimination is not favorable.  In either case, we had hoped 
to facilitate the transmetallation step and/ or the reductive elimination step by 
reducing the steric bulk about the metal center and thereby favoring the desired 
pathway.   
 As was discussed previously, in terms of functionality, the compound used in 
model investigations differed only in that it lacked two hydroxyl groups, which were 
present in the actual system.  The model compound 77 easily yielded to the reaction 
conditions and gave the desired allylic arylation products; surprisingly, allyl carbonate 
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83 was unreactive to the same conditions.  Therefore, it would lend that either the cis 
hydroxyls and/or their protecting group are impeding efficient coupling (Figure 2). 
 In an effort to troubleshoot the coupling reaction we: 1) used molecular 
modeling to investigate the possible energy barriers impeding our reaction and 2). 
varied the protecting groups on the cis diols to experimentally access these same 
barriers. 
 All molecular modeling experiments were performed using a Piroda DFT 
calculator85,86 and were completed by Dr. Andrei Vedernikov.  The first set of data 
collected investigated the oxidative addition of palladium (0) into substrates 110, 111, 
and 112.  The calculations have shown that oxidative addition into 112, is  
 
Figure 4. Substrates Evaluated Using Molecular Modeling. 
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less favored by 4 kcal/mol compared with 110 and 111.  This data supports the 
hypothesis that the cis diols constrained to a ring as in 112 are too sterically 
constrained to undergo allylic arylation.  As a matter of conformation, oxidative 
addition requires palladium to be planar with the three carbons atoms of the pi-allyl 
system.  One would expect that planarity would be easier for monocyclic systems 
110 and 111.  For 112, the planarity that would be required for oxidative addition 
would severely destabilize the bicycle due to immense torsional and steric strain of 
such an unfavored conformation.   
Calculation data was also collected to provide insight into the reductive 
elimination sequence.  This step in the catalytic cycle was scrutinized based on the 
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information described previously in Scheme 25, namely that allylic carbonate 83 
effectively couples with soft nucleophiles, but not with hard nucleophiles such as 78.  
In this light, the relative Gibbs energies for the two transition state extremes (113 and 
114) were modeled.  The data has shown that the Gibbs activation energy for 113 is 
20.8 kcal/mol.  For 114 the Gibbs activation energy was calculated to be 18.2 
kcal/mol.  The higher energy calculated for 113 over 114 can be rationalized by the 
unfavorable steric interaction between the phenyl ring on the palladium and the axial 
methoxy substituent.   
The three conclusions drawn from this calculation data were 1) oxidative 
addition may be impeded by the presence of a fused ring system 2) sterics 
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also play an important role in the reductive elimination step and 3) if reductive 
elimination is the rate determining step, the reductive elimination should favor the 
formation of a 1-4 phenylated product (as predicted) over the possible 1-2 
phenylated product.   
 Given that the molecular modeling calculations have shown that the coupling 
reaction utilizing isopropylidene protected diol compound 83 is less energetically 
favorable than its acyclic protective counterpart we sought to investigate protecting 
group alternatives.   A variety of protecting groups were investigated during the 
course of this synthesis.   
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Early in the synthesis we had defined a series of requirements for any 
protecting group employed in the synthesis.  First, the group should be relatively 
small and the cis hydroxyl groups should not be confined to a ring as in 83.  The 
protecting group should also withstand the basic coupling reaction conditions and 
should be removable at the end of the reaction.  Common protecting groups that 
were immediately eliminated included acetates, which are known to hydrolyze under 
our coupling conditions.  Additionally, silyl protecting groups were eliminated as they 
are readily cleaved in the presence of fluoride – another necessary component of our 
coupling reactions. 
 An obvious first choice was the protection of the diols as their dimethyl 
ethers.  The literature is abundant with protocols for achieving this transformation 
under either acidic or basic conditions.  Despite the fact that methylation of an 
aliphatic alcohol is essentially an irreversible process, coupling of this analogue 
would provide valuable insight into the coupling process.  The success of this 
coupling would validate the hypothesis that the isopropylidene protecting group 
sterically impeded the reaction. 
A multitude of methylation procedures and reagents were attempted, but all 
were unsuccessful in the preparation of dimethylated analogue of allylic carbonate 
83.  Methylation was also attempted at a variety of stages in the synthetic sequence.  
Logically, protection was initially attempted early in the synthesis at to avoid a series 
of protections and deprotections .  Dibromodiol 88 was subjected to numerous 
methylation conditions.  The first attempt at methylation utilized methyl iodide and a 
general base, triisopropylethylamine.  Unfortunately the dibromodiol was resistant to 
methylation and only starting material was isolated.  Variants on this traditional 
methylation procedure were attempted using a variety of bases.  Strong bases such 
as potassium hydroxide and sodium hydride resulted in decomposition of the 
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substrate due to competing elimination reactions, even at low temperatures.  
Stronger methylation agents were also investigated; they included trimethyl oxonium 
tetrafluoroborate, diazomethane, and dimethylsulfate.  Although the dibromodiol was 
not completely unreactive to these conditions, only mixtures of monoalkylated 
products were isolated.  The reactions could not be driven to completion even upon 
extended reaction times (> 7 days) at high temperatures (reflux).   
 Hoping to protect the cis diol as its dimethyl ether derivative, the protection 
was attempted at other points in the synthesis, for example, at bicycle 90 or 94.  One 
advantage to protecting the diol at this stage was the fact that the bicycles 90 and 94 
were far less acid and base sensitive than dibromodiol 88.  One disadvantage to 
performing the protection at this point was that additional steps would be added to 
the synthesis, i.e. the isopropylidene would be present early in the synthesis and 
would later be replaced by the dimethyl ethers.  Unfortunately, methylation, even 
monomethylation could not be accomplished.  More vigorous conditions were again 
employed (refluxing dimethyl sulfate), but methylation was not observed.   
 At this point, the synthetic strategy was revised slightly.  Initially, attempts 
were made to protect the cis diol with some aliphatic protecting group.  Sensing 
methylation was not feasible, other potential protecting group targets were 
investigated.  Toward this end, diallyl ethers were examined as potential protecting 
groups for the diol.  Allyl protecting groups are well known in carbohydrate chemistry 
and the ring C of pancratistatin bears some resemblance to a sugar87-95.  
Unfortunately, after several unsuccessful attempts, allylation chemistry was 
abandoned.  
 Again the synthetic strategy was revamped.  Due to the lack of success at 
protecting the cis diol in an acyclic fashion, a ring size larger than that of the 
isopropylidene (5 membered) was considered as it might facilitate efficient allylic 
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arylation.  In this regard, attempts were made to prepare 6-membered bis-acetal 117.  
Again this chemistry is well established in the literature96,97.  Treatment of bicyclic diol 
115 with 2,3-butadione, trimethylorthoformate, and a catalytic amount of camphor 
sulfonic acid, did not afford the desired product.  Surprisingly, the five-membered 
adduct 116 was preferentially formed and the structure determined by single X-ray 
crystallographic analysis upon the cleavage of the N-O bond and subsequent 
protection of the allylic alcohol as the ethyl carbonate (Appendix A).   
 The final strategy toward the completion of this project was to prepare the six 
membered analogue of 119 – a less rigid and more conformationally flexible 
analogue of 83.  Diol 118 was treated with 2,3-butadione, trimethylorthoformate, and 
a catalytic amount of camphor sulfonic acid.  A mixture of products 119 were 
obtained which was inseparable by flash chromatography.   
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 The synthetic difficulties described herein are characteristic of the difficulties 
experienced by all chemists targeting the 7-deoxypancratistatin, specifically 
achieving the requisite functionality for the C ring.  Unfortunately, the work towards 
validating the siloxane mediated allylic arylation as a viable approach towards the 
synthesis of this family of compounds is incomplete.  However, much knowledge has 
been gained to aid in this effort.  First the synthetic route to allylic carbonate 83 has 
been optimized.  Several key control experiments have also provided invaluable 
insight into this complex system.   
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Scheme 29. 
 
 
 Future work for the completion of this project will involve the separation of the 
diastereomeric bisacetals 119 and its successful coupling with aryl siloxane 78.  
Alternatively, the cis diol moiety must be alternatively protected.  Experience has 
shown that this protection must include the incorporation of an acetonide or 
bisacetal-like group as the molecule is resistant to the incorporation of an acyclic 
protection group.   The appropriate protection the cis diols should hopefully facilitate 
the completion of the total synthesis.   
Experimental 
Thin-layer chromatography (TLC) was performed on 0.25 mm Merck silica gel 
coated plates treated with a UV-active binder with compounds being identified by 
one or more of the following methods:  UV (254 nm), iodine, vanillin/sulfuric acid 
charring, KMnO4 charring, or p-anisaldehyde charring.  Flash chromatography was 
performed using a thick walled columns and medium pressure silica gel (Whatman 
200-245 mesh), with column length and diameter being determined by the method of 
Still.98 
Melting points were taken in Kimax soft glass capillary tubes using a Thomas-
Hoover Uni-Melt capillary melting point apparatus (Model 6406K) equipped with a 
calibrated thermometer.  Melting points are corrected. 
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Infrared spectra were recorded on a Nicolet 5DXC FT-IR spectrophotometer.  
Samples were either dissolved in carbon tetrachloride, prepared as a potassium 
bromide pellet or as a Nujol mull.  Band positions are reported in reciprocal 
centimeters (cm-1) and relative intensities are listed as br (broad), s (strong), m 
(medium), or w (weak). 
 Nuclear magnetic resonance (1H, 13C NMR) spectra were recorded on a 
Bruker DRX-400 spectrometer.  Chemical shifts are reported in parts per million (δ) 
relative to tetramethylsilane (TMS). Coupling constants (J values) are reported in 
Hertz (Hz), and spin multiplicities are indicated by the following symbols:  s (singlet), 
d (doublet), t (triplet), q (quartet), m (multiplet), and br s (broad singlet). 
 Low resolution mass spectrometry (LRMS) and high resolution mass 
spectrometry (HRMS) were obtained on a VG-7070E magnetic sector instrument.   
 Gas chromatography was performed on a Hewlett Packard 5890 GC 
equipped with a flame ionization detector using a 25m methyl silicon column. 
 Tetrahydrofuran (THF) and diethyl ether were distilled from 
sodium/benzophenone ketyl.  Methylene chloride, tetraethylorthosilicate, and 
pyridine were distilled from calcium hydride.  Dimethylformamide (DMF) was distilled 
from calcium sulfate.  Benzene was stored over 4 Å molecular sieves prior to use.    
 Bis(dibenzylideneacetone)palladium (Pd(dba)2), and allylpalladium chloride 
dimer ((allylPdCl)2) were purchased from Acros and used as received.  Triphenyl 
phosphine (PPh3) was purchased from Aldrich and recrystallized from hexanes prior 
to use.  All other reagents were bought from commercial sources and used without 
purification unless otherwise noted.   
 All glassware used in these reactions was either oven dried at 120°C for 12 
hours or flame dried prior to use.  All reactions were conducted under an atmosphere 
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of anhydrous argon. 
 All compounds were determined to be >95% pure by 1H NMR or GC analysis, 
unless otherwise noted.  Previously reported compounds were characterized by 1H 
NMR, 13C NMR, and IR and compared to literature values.  All new compounds were 
characterized using 1H NMR, 13C NMR, IR, low resolution, and high resolution mass 
spectroscopy. 
 
The dibromide 87 was prepared from 1,4-cycohexadiene according to the 
procedure of Yang.76 To 21.2 g of 1,4-cyclohexadiene (264 mmol) in 60 ml 
of CHCl3 at –78 °C was added 13.6 ml of Br2  (264 mmol) dropwise over 2 h.  The 
reaction mixture was allowed to stir for 45 minutes and the reaction was quenched 
by the addition of 100 ml of a 10% aqueous sodium thiosulfate.  The mixture was 
extracted with CHCl3 (3 x 100 ml).  The combined organic extracts were washed with 
brine (1 x 100 ml), dried over MgSO4, filtered, and concentrated in vacuo to afford 
27.4 g (44%) of dibromide 87 as a white solid, mp 35-36 °C (lit.76 34 - 37°C), which 
was used without further purification.  IR (CCl4) 3040 (w), 2943 (w), 2881 (w), 2819 
(w), 2365 (w), 2322 (w), 1421 (m) cm-1.  1H NMR (CDCl3) δ 2.58 (d, J = 19Hz, 2H), 
3.17 (d, J = 19Hz, 2H), 4.50 (s, 2H), 5.65 (s, 2H).  13C NMR (CDCl3) δ 122.4, 48.8, 
31.5.  LRMS (EI+) m/z 240 (M+ 25), 161 (23), 159 (25), 79 (100), 77 (38).  
 
To 27.4 g (115 mmol) of the dibromoalkene 87 in 680 ml of acetone 
and 74 ml H2O was added 20.2 g (173 mmol) N-methylmorpholine N-
oxide hydrate followed by 250 mg (0.98 mmol) of OsO4 at room temperature with 
stirring.  The heterogeneous yellow solution became homogeneous within 2 h.  The 
reaction was allowed to stir at room temperature for 24 h and was quenched by the 
Br
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addition of 280 mg (1.47 mmol) sodium metabisulfite in 100 ml H2O.  The solution 
was concentrated in vacuo to 200 ml and extracted with Et2O (3 x 350 ml).  The 
combined organic extracts were dried over MgSO4, filtered, and concentrated in 
vacuo to afford a white solid.  Recrystallization from chloroform afforded 31.5 g (99 
%) of the dibromodiol 88 as a white solid, mp 89-91°C (lit.76 103-105 °C).  IR (CCl4) 
3491-2953 (br s), 2951 (w), 2889 (w), 1685 (w) cm-1.  1H NMR (py - d5) δ 2.15 (ddd, J 
= 15, 12, 2, 1H), 2.71 (dddd, J = 12, 4,4, 1, 1H), 2.84 (ddd, J = 15, 4, 3, 1H), 2.94 
(ddd, J = 12, 12, 11 Hz, 1H), 3.98 (ddd, J = 12, 4, 3, 1H), 4.26 (m, 1H), 4.40 (ddd, J = 
12, 11, 4, 1H), 4.86 (ddd, J = 12, 11, 4, 1H), 6.11 (br s, 2H).  13C NMR (py-d5) δ 42.1, 
43.7, 55.6, 56.5, 70.9, 71.5.  LRMS (EI+) m/z 274 (M+, 5), 195 (90), 193 (95), 177 
(78), 175 (98), 113 (28), 95 (100), 67 (94), 55 (51). The IR, 1H NMR, and 13C NMR 
spectra matched that previously reported in the literature.99 
 To 26.0 g (94.9 mmol) of the dibromodiol 88 in 1L CH2Cl2 was 
added 120 g (141 ml, 1.14 mol) of 2,3-dimethoxypropane dropwise 
followed by 500 mg of p-toluenesulfonic acid monohydrate.  The reaction was 
allowed to stir for 12 hours and was then diluted with saturated NaHCO3 (1 x 500 ml) 
and extracted with CH2Cl2 (3 x 500 ml).  The combined organic extracts were dried 
over MgSO4, filtered, and concentrated in vacuo to give a yellow oil.  Purification by 
column chromatography (25% EtOAc/Hexanes; Rf 0.3) afforded 29.8 g (99%) of the 
acetonide protected diol 89 as a yellow oil.  IR (CCl4) 2990 (m), 2932 (m), 2877 (m), 
2827 (w), 1720 (w), 1456 (m) cm-1.  1H NMR (CDCl3) δ 1.31 (s, 3H), 1.51 (s, 3H), 
2.20 (m, 1H), 2.36 (m, 1H), 2.71-2.75 (m, 2H), 4.15-4.20 (m, 2H), 4.26-4.30 (m 1H), 
4.39-4.43 (m, 1H).  13C NMR (CDCl3) δ 26.5, 28.7, 35.0, 36.5, 49.4, 51.6, 72.6, 73.0, 
109.4.  1H NMR, and 13C NMR spectral data match that previously reported in the 
literature.77 
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The diene 85 was prepared according to the procedure of Yang.76  To 
29.8 g (94.9 mmol) of the isopropylidene 89 in 1500 ml of benzene was 
added 34.1 ml (52.0 g, 342 mmol) of DBU dropwise using an addition funnel.  The 
yellow heterogeneous mixture was heated at reflux for 11 hours.  The HBr was 
removed by vacuum filtration and the filtrate was diluted with saturated NaHCO3 (1 x 
150 ml) and extracted with benzene (3 x 200 ml).  The combined organic layers were 
dried over MgSO4, filtered, and concentrated in vacuo to give a yellow oil.  Column 
chromatography (33% CH2Cl2/Pentane, Rf 0.25) afforded 14.4 g (40%) of diene 85 
as a yellow oil.  IR (CCl4) 3049 (m), 2986 (m), 2928 (m), 2862 (m), 2792 (w), 2769 
(w), 1961 (w), 1472 (w), 1441 (m), 1383 (m), 1351 (m), 1243 (m), 1216 (m) cm-1.  1H 
NMR (CDCl3) δ 1.38 (s, 3H), 1.40 (s, 3H), 3.46 (s, 2H), 5.87 (m, 2H), 5.96 (m, 2H). 
13C NMR (CDCl3) δ 25.2, 27.8, 70.2, 104.5, 123.7, 126.7.  1H and 13C spectral data 
match that previously reported in the literature.77 
 
To 18.0 ml (16.6 g, 0.170 mmol) of cyclohexanone in 500 ml H2O was added 
21.9 g NaHCO3 followed by NH2OH-HCl portion wise.  Vigorous bubbling 
occurred.  The reaction was allowed to proceed for 30 minutes at room temperature.  
The solid product was collected via vacuum filtration.  Recrystallization from hexanes 
afforded the product, cyclohexanone oxime, as a white solid, mp 88-90 °C (lit.100 91 
°C).  IR (KBr) 3221 (br s), 1691 (m), 942 (s) cm-1.  1H NMR (CDCl3) δ 1.63 (m, 6H), 
2.19 (t, J= 6 Hz, 2H), 2.49 (t, J = 6 Hz, 2H). 13C NMR (CDCl3) δ 24.4, 25.6, 25.8, 
26.8, 32.1, 160.7.  The spectral data was identical to that reported by Hwu.101 
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To 7.25 g (64.0 mmol) of the cyclohexanone oxime in 56 mL Et2O was added 
189 mL of 0.338 M HOCl dropwise with stirring under an atmosphere of 
argon.  Upon the addition of HOCl, the reaction solution turned blue.  The 
reaction was allowed to stir 30 minutes following the addition of HOCl and then 
diluted with water (1 x 100 ml) and extracted with Et2O (3 x 100 ml).   The combined 
organic layers were dried over MgSO4, filtered, and concentrated to afford a blue oil.  
Purification by column chromatography (100% pentane, Rf 0.35) afforded 4.25 g 
(46%) of the α-chloronitroso compound as a blue oil.  IR (CCl4) 3600 (m), 3417-3126 
(s br), 2936 (m), 2854 (m), 2664 (w), 2357 (w), 2334 (w), 1713 (m), 1573 (m), 1557 
(m), 1449 (m), 1425 (m), 1344 (w), 1309 (w), 1250 (w), 1223 (w) cm-1.  Further 
characterization was not attempted due to the instability of the compound.  The IR 
data was identical to that reported by Corey.78 
 
To 3.80 g (25.4 mmol) of the diene 85 in 8 ml Et2O and 2 ml EtOH 
was added 3.97 g (26.7 mmol) of the α-chloronitroso 84 in 8 ml Et2O.  
The homogeneous blue mixture was stirred under argon for 30 
minutes and then placed in the freezer at 0 °C for 5 days at which time all the blue 
color had disappeared.   The solid yellow product was collected by gravity filtration, 
was washed with cold EtOH to afford 3.66 g (62%) of the Diels Alder adduct 90 as a 
white solid (mp 135°C - 160 °C decomp., lit.102 180-182 °C decomp).  IR (nujol) 2954 
(m), 2923 (m), 2850 (m), 1460 (w), 1370 (w) cm-1.  1H NMR (CDCl3) δ 1.22-1.25 (m, 
6 H), 4.56 (m, 1H), 4.75 (m, 1H), 4.92 (m, 1H), 5.25 (m, 1H), 6.50-6.51 (m, 1H), 6.68-
6.70 (m, 1H).  13C NMR (d6 - DMSO) δ 52.1, 52.3, 76.8, 95.8, 97.4, 98.7, 137.2, 
155.0, 160.0.  LRMS (FAB) m/z 367.1 (2M+ 12), 184.1 (100).  HRMS (FAB) calcd for  
184.0974, found 184.0974.  The IR, 1H NMR, and 13C NMR spectra matched that 
previously reported in the literature.102 
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The amino alcohol 91 was prepared according to the procedure of Elango 
and Yan.103  To 3.66 g (16.7 mmol) of the Diels Alder adduct 90 in 100 ml 
THF and 10 ml H2O was added  3.15 g (117 mmol) of Al(Hg) amalgam.  
The amalgam was prepared by exposing 3.15 g (117 mmol) of aluminum foil to 50 ml 
of each of the following for 20 seconds each:  1M KOH, distilled H2O, 0.5% HgCl2, 
distilled H2O, and THF.  The amalgam was then added to the reaction mixture 
containing the Diels Alder adduct.  The gray heterogeneous mixture was allowed to 
stir at 0 °C under argon for 12 hours and was then filtered through Celite and 
concentrated in vacuo to afford 3.6 g (100%) of the amino alcohol, 91 as a white 
solid which, was used without further purification.  IR (CCl4) 3700-3300 (br s), 3090 
(m), 2990 (m), 2600 (w), 1625 (w), 1470 (w) cm-1.  1H NMR (d6 - DMSO) δ 1.30 (s, 
3H), 1.39 (s, 3H), 3.45 (m, 1H), 3.98-4.03 (m, 3H), 5.58-5.62 (m, 1H), 5.76-5.81 (m, 
1H).  13C NMR (CD3OD) δ 24.3,  26.8, 51.7,  69.7, 78.4, 80.2, 110.0, 128.2, 133.4.  
LRMS (FAB) m/z 186 (100), 110 (33), 45 (43).  HRMS (FAB) calcd 186.1130, found 
186.1121.  1H and 13C spectral data match that previously reported in the 
literature.103 
 
 
To 2.57 g (10.1 mmol) of the amino alcohol 91 in 12.5 MeOH and 53 ml 
of acetone was added 4.27 g (40.4 mmol) Na2CO3 and 3.28 g (2.89 ml, 
30.3 mmol) of ethylchloroformate.  The solution was stirred for 45 
minutes and then was concentrated in vacuo.  The crude oil was diluted with 100 ml 
of saturated NaHCO3 and extracted with CH2Cl2 (3 x 100 ml).  The combined organic 
layers were dried over MgSO4, filtered and concentrated to afford 2.18 g (85%) of the 
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carbamate 92 as a white solid.  The compound was used without further purification.  
IR (CCl4) 3617 (w), 3451 (w), 2988 (w), 2902 (w), 1735 (s), 1545 (m), 1210 (m) cm-1.  
1H NMR (CDCl3) δ 1.23 (t, J = 7 Hz, 3H), 1.33 (s, 3H), 1.43 (s, 3H), 2.47 (br s, 1H), 
4.11 (m, 3H), 4.19-4.24 (m, 3H), 5.14 (br s, 1H), 5.81-5.78 (m, 1H), 5.90 - 5.93 (m, 
1H) cm-1.  13C NMR (d6-DMSO) δ 14.6, 25.0, 27.2, 51.5, 59.7, 69.2, 75.9, 79.8, 
107.9, 129.5, 132.6, 155.9.  LRMS (FAB) m/z 258 (M+1+, 42), 240 (66), 182 (70), 
154 (63), 110 (100); HRMS m/z calcd. 258.1342, found 258,1341. IR, 1H and 13C 
spectral data match that previously reported in the literature.104 
 
 
 
To 2.18 g (8.47 mmol) of the carbamate 92 in 78 ml CH2Cl2 was added 
19.4 ml of anhydrous pyridine and 1.38 g (2 ml, 12.71 mmol) of 
anhydrous ethylchloroformate which caused the evolution of a yellow 
gas from the reaction solution upon the addition.  The yellow solution was stirred for 
48 hours and was then diluted with 150 ml CH2Cl2 and washed with saturated NaCl 
(1 x 150 ml) and extracted with CH2Cl2 (3 x 100 ml).  The combined organic extracts 
were dried over MgSO4, filtered, and concentrated to afford the carbonate 83 as a 
white solid.  Purification by column chromatography (10% to 25% EtOAc/hexanes, 
gradient elution, Rf 0.1) afforded 2.26 g  (81%) of a white solid.  IR (CCl4) 3437 (w), 
2988 (w), 2937 (2), 1749 (s), 1728 (s), 1552 (s) cm-1.  1H NMR (CDCl3) δ 1.17 (m, 
3H), 1.25 (m, 6H), 1.39 (m, 3H), 4.06 (m, 2H), 4.15 (m, 4H), 4.28 (m, 1H), 5.06 (m, 
1H), 5.21 (br s, 1H), 5.81 (m, 2H).  13C NMR (CDCl3) δ 14.1, 14.4, 24.8, 26.8, 50.3, 
60.9, 64.3, 74.0, 75.8, 76.0, 109.2, 126.9, 131.3, 154.2, 156.0.  LRMS (FAB) m/z 330 
(M+1+, 6), 154(38), 136(40), 73(48); HRMS (FAB) calcd (M + 1)+ 330.1553, found 
330.1553. IR, 1H and 13C spectral data match that previously reported in the 
literature.104 
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To 1.5 g (62.5 mmol) of magnesium turnings in 10 ml of 
anhydrous THF was added 8.38 g (41.6 mmol) of the aryl 
bromide 97 dropwise with stirring.  After the reaction became 
warm, an additional 30 ml of THF was added to the mixture.  After 48 hours, the 
Grignard mixture was cannulated into 13.1 g of Si(OEt)4 in 60 ml anhydrous THF.  
The solution was allowed to stir for 48 hours.  The solution was then diluted with 100 
ml H2O and extracted with Et2O (3 x 100 ml), dried over MgSO4, filtered, and 
concentrated in vacuo to a brown oil.  After a Kugelrohr distillation (0.3 atm, 100-
120°C), the desired aryl siloxane 78 was obtained as a colorless oil, 4.8 g (40%).  IR 
3056 (w), 2971 (m), 2932 (m), 2885 (m), 2773 (w), 2834 (w), 1876 (w), 1619 (w), 
1603 (w), 1507 (m), 1484 (m), 1425 (m), 1390 (m), 1239 (m) cm-1.  1H NMR (CDCl3) 
δ 1.36 (t, J = 7 Hz, 9H), 3.98 (q, J = 7 Hz, 6H), 6.05 (s, 2H), 6.97 (d, J = 8 Hz, 1H), 
7.24 (s, 1H), 7.31 (d, J = 8 Hz, 1H).  13C NMR (CDCl3) δ 16.5, 57.0, 98.9, 106.9, 
112.3, 122.1, 127.7, 145.7, 147.8. LRMS (FAB) 284.4 (M+, 100), 283.4 (42), 239 
(80), 161 (65).  HRMS (FAB) calcd. 284.1080 (M+), found 284.1080.  The spectral 
data was identical to that reported by Manoso.19 
 
To a solution of 0.22 g of siloxane 78 (0.39 mmol) and 100 mg 
carbonate 77 (0.20 mmol) in 5 ml THF was added 20 mg 
Pd2dba3-CHCl3 (5 mol %) to give a deep purple solution. Lastly, 
tetrabutylammonium fluoride (0.8 ml, 1M in THF) was added and the amber reaction 
mixture was subjected to one freeze-pump-thaw cycle. The reaction mixture was 
heated to 55 °C for 20h, cooled and quenched by the addition of water (10 ml). The 
black suspension was extracted with ether (3 x 40 ml), dried over MgSO4 and 
O
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concentrated in vacuo. Flash chromatography on silica gel (25 % EtOAc/hex, Rf = 
0.38) gave 75 mg (67%) of 99 and its regioisomer in a 1:1 ratio. A small amount of 
the mixture was separated on preparative HPLC (25% EtOAc/hex) for spectral 
analysis.  IR (CCl4) 3447 (w), 3029 (w), 2933 (w), 1729 (s), 1552 (s) cm-1.  1H NMR 
(CDCl3) δ 6.73-6.67 (m, 3H), 5.91 (s, 2H), 5.87 (d, J = 10 Hz, 1H), 5.66 (d, J = 10 Hz, 
1H), 4.76-4.74 (m, 1H), 4.03 (q, J = 7 Hz, 2H), 3.74-3.71 (m, 1H), 3.23-3.21 (m, 1H), 
2.20-2.04 (m, 2H), 1.90-1.86 (m, 1H), 1.62-1.53 (m, 1H), 1.18 (t, J = 7 Hz, 3H).  13C 
NMR (CDCl3) δ 156.0, 147.6, 146.2, 136.5, 128.0, 127.9, 121.5, 108.7, 108.0, 100.9, 
60.6, 52.7, 47.6, 25.5, 22.9, 14.5; LRMS (FAB) m/z 290 ((M+H)+, 21), 201 (100), 174 
(31), 135 (81), 73 (90); HRMS (FAB) calcd for C16H20O4N (M+H)+ 290.1392, found 
290.1379.  
  
To 158 mg (0.404 mmol) of allyl carbonate 96 in 
2 ml THF was added 16 mg (0.061 mmol) of 
triphenylphosphine and 7.4 mg (0.020 mmol) of 
allyl palladium chloride dimer.  The reaction was 
allowed to stir under an atmosphere of argon.  Immediately, 68 mg (0.424 mmol) of 
deprtonated diethyl malonate in1 ml of THF was cannulated into the allyl carbonate 
reaction mixture.  The amber reaction mixture was subjected to one freeze-pump-
thaw cycle. The reaction mixture was heated to 55 °C for 20h, cooled and quenched 
by the addition of water (10 ml). The black suspension was extracted with ether (3 x 
40 ml), dried over MgSO4 and concentrated in vacuo.  Purification by column 
chromatography (20 % EtOAc/hex, Rf = 0.13) afforded 186 mg (32%) of the desired 
product 103 as a white solid.  IR (CCl4) 3441 (m), 3029 (w), 2990 (m), 2936 (m), 
2897 (w), 2365 (w), 2338 (w), 1755 (s), 1732 (s), 1503 (s), 1375 (m), 1212 (s), 1049 
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(m) cm-1.  1H NMR (CDCl3) δ 1.20-1.24 (m, 6H), 1.34 (s, 3H), 1.45 (s, 3H), 3.45 (s, 
2H), 4.08-4.21 (m, 5 H), 4.30 (s, 2H), 4.52 (s, 1H), 5.06 (s, 2H), 5.73-5.81 (m, 2H), 
7.24-7.33 (m, 5H).  13C NMR (CDCl3) δ 13.9, 14.0, 26.2, 27.7, 34.6, 51.2, 52.6, 
61.7,61.9, 67.0, 70.6, 74.2, 77.2, 109.7, 127.3, 128.2, 128.3, 128.5 136.0, 155.8, 
167.8, 168.4.  LRMS (FAB) m/z 462 (10), 404 (50), 91 (100); HRMS (FAB) calcd for 
C24H31NO8 462.2128, found 462.2131.   
 
To 2.60 g (17.1 mmol) of diene 85 was added 193 ml of CHCl3, 150 
ml DMF, and 10.4 g (24 mmol) of tetrabutylammonium periodate.  
Using a solid addition funnel 3.2 g (24.0 mmol) of hydroxamic acid 
93 was added portionwise over 2 hours.  The light yellow and heterogeneous 
solution was stirred under argon for 48 hours at which time the reaction mixture had 
turned dark yellow in color.  The reaction was diluted with CH2Cl2 and washed with 
H2O (3 x 150 ml).  The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo to afford a dark brown oil.  Purification by column 
chromatography (20% EtOAc/Hexanes, Rf 0.21) afforded 2.54 g (94%) of the Diels 
Alder adduct 94 as a light yellow solid.  IR (CCl4) 3607 (m), 3087(w), 3067(m), 
3029(m), 2932(m), 2873(m), 2361(w), 2330 (w), 1775 (s), 1708 (s), 1499 (m), 1456 
(s), 1382 (m), 1328 (m), 1242 (s), 1207 (s) cm-1. 1H NMR (CDCl3) δ 2.28 (s, 3H), 2.29 
(s, 3H), 4.48-4.55 (m, 2H), 4.89 (m, 1H), 5.05-5.06 (m, 1H), 5.10-5.21 (ABX system, 
J = 12 Hz, 2H), 6.39-6.43 (m, 2H), 7.30-7.36 (m, 5H). 13C NMR (CDCl3) δ 25.4, 25.6, 
53.0, 68.2, 71.3, 72.5,73.1,111.0,128.1, 128.4,128.5, 129.5,130.5,135.5,157.8. 
LRMS (FAB) m/z 635 (2M + H, 12), 318 (100), 274 (30), 216 (20), 152 (20), 91 (90), 
85 (35); HRMS (FAB) calcd for C17H19NO4 (M + H)+ 318.1336, found 318.1341.   
 
N
O
O
O
CBz
94
  49 
 
To 3.31 g (15.46 mmol) of the Diels-Alder adduct  94 dissolved in 260 
mL of CH3CN and 12 mL H2O was added 816 mg (3.09mmol) of 
Mo(CO)6 and 1.20 g (30.9 mmol) NaBH4 portionwise.  The reaction 
mixture was heated at reflux under an atmosphere of argon for 12 hours.  Upon 
cooling, the mixture was filtered through a plug of SiO2 and concentrated to a dark 
brown oil.  Purification by column chromatography (20% EtOAc/Hexanes, Rf 0.14) 
afforded 4.50 g (91%) of the allylic alcohol 95 as a colorless oil.  IR (neat) 3463 (br 
m), 3300 (br, m,) 3043 (w), 2985 (w), 2903 (w), 1678 (s), 1544 (m), 1269 (m) cm-1.  
1H NMR (CH3OD) δ 1.33 (s, 3H), 1.43 (s, 3H), 2.03 (br s, 1H), 4.12-4.15 (m, 1H), 
4.21-4.24 (m, 3H), 5.06-5.14 (m, 2H), 5.24 (br s, 1H), 5.80-5.82 (d, J = 9 Hz, 1H), 
5.91-5.94 (d, J = 9 Hz, 1H), 7.30-7.38 (m, 5H).  13C NMR (CH3OD) δ 25.6, 28.0, 53.6, 
68.0, 71.6, 78.5, 81.6, 110.7, 129.3, 129.5, 129.9, 130.9, 133.4, 138.7, 158.9. LRMS 
(FAB) m/z 320 (M +, 35), 302 (30), 262 (15), 135 (20), 91 (100), 85 (25).   
 
To 1.16 g (3.60 mmol) of the allylic alcohol 95 in 10 ml CH2Cl2 was added 
40.0 ml of anhydrous pyridine and 590 mg (520 µl, 5.45 mmol) of 
anhydrous ethylchloroformate which caused the evolution of a yellow gas 
from the reaction solution upon the addition.  The yellow solution was stirred for 48 
hours and was then diluted with 150 ml CH2Cl2 and washed with saturated NaCl (1 x 
150 ml) and extracted with CH2Cl2 (3 x 100 ml).  The combined organic extracts were 
dried over MgSO4, filtered, and concentrated to afford the carbonate 96 as a white 
solid.  Purification by column chromatography (20% EtOAc/hexanes, Rf 0.28) 
afforded 1.14 g (81%) of the product as a white solid.  IR (CCl4) 3370 (br m), 2979 
(w), 2932 (w), 2366 (w), 2331 (w), 1748 (s), 1701 (s), 1514 (m), 1456 (w), 1374 (w), 
1246 (s) cm-1.  1H NMR (CDCl3) δ 1.28-1.32 (m, 6H), 1.44 (s, 3H), 4.20-4.23 (m, 4H), 
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4.40 (s, 1H), 5.10-5.11 (m, 4H), 5.89 (m, 2H), 7.34-7.35 (m, 5H).  13C NMR (CDCl3) 
δ 14.1, 24.8, 26.9, 29.7, 50.3, 64.4, 67.0, 73.8, 75.8, 76.1, 109.3, 127.2, 128.2, 
128.5, 131.2, 136.2, 154.3, 155.8. LRMS (FAB) m/z 392 (M +, 23), 302 (90), 258 
(18), 154 (21), 110 (25), 91 (100).  HRMS (FAB) calcd for C20H25NO7 (M + H)+ 
392.1729, found 392.1709.   
 
The Diels-Alder adduct 94 2.54 g (9.16 mmol) was dissolved in 50 
ml THF.  To the reaction solution was added 50 ml of 1N HCl.  The 
white reaction mixture was then heated at reflux for 12 hours.  The THF was 
removed in vacuo and the remaining solution was diluted with CH2Cl2 and extracted 
with 150 ml CH2Cl2 (3x).  Purification by column chromatography (50% 
EtOAc/Hexanes, Rf 0.14) afforded 1.8 g (77%) of the desired diol as a colorless oil.   
IR (neat) 3500-3000 (br s), 2925 (w), 1810 (w), 1699 (s), 1389 (w), 1246 (m) cm-1.  
1H NMR (CDCl3) δ 2.49 (m, 1H), 2.67 (m, 1H), 4.28 (s, 2H), 4.77 (m, 1H), 4.92 (m, 
1H), 5.20 – 5.10 (ABX system, J = 12 Hz, 2H), 6.54-6.50 (m, 1H), 6.56-6.59 (m, 1H), 
7.28-7.36 (m, 5H).  13C NMR (CDCl3) δ 54.4, 65.0, 65.7, 68.3, 72.3, 128.1, 128.4, 
128.6, 130.5, 131.7, 135.4, 157.8.  LRMS (EI) m/z 277 (8), 111 (12), 91 (100), 65 
(18).   
 
The acetonide 83 2.50 g (7.50 mmol) was dissolved in 120 ml THF and 
120 ml 1M HCl.  The reaction was stirred at room temperature overnight.  
The THF was removed in vacuo and the remaining solution was diluted 
with CH2Cl2 and extracted with 150 ml CH2Cl2 (3x).  The organic layers were dried 
over MgSO4, filtered and concentrated to afford 1.17 g (54%) of a white crystalline 
solid (mp 113-115 °C) that was used without further purification.  IR (CCl4) 3448 (m), 
N
O
OH
OH
CBz
OCO2Et
NHCO2Et
OH
OH
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3409 (m), 2978 (w), 2935 (w), 2376 (w), 2330 (w), 1747 (s), 1693 (s) cm-1.  1H NMR 
(CDCl3) δ 1.24 (t, J = 7 Hz, 3H), 1.30 (t, J = 7 Hz, 3H), 3.24 (s, 1H), 3.85 (m, 2H), 
4.00 (s, 1H), 4.12 (q, J = 7 Hz, 2H), 4.20 (q, J = 7 Hz, 2H), 4.36 (br s, 1H), 4.83 (m, 
1H), 5.18 (m, 1H), 5.73 (m, 1H), 5.83 (m, 1H).  13C NMR (CDCl3) δ 17.5, 17.9, 55.8, 
64.8, 68.1, 73.9, 75.4, 79.4, 129.5, 134.5, 159.3, 161.8.  LRMS (FAB) m/z 290 (27), 
200 (100), 152 (15), 111 (15), 90 (12).  HRMS (FAB) calcd for C12H19NO7 (M + H)+ 
290.1240, found 290.1237.   
 
To 300 mg (1.08 mmol) of diol 115 in 4 ml of methanol was added 
27.6 mg (0.119 mmol) of camphor sulfonic acid, 233 mg (237 µl, 
2.71 mmol) of butanediol, and 916 mg (945 µl, 8.64 mmol) of 
timethylorthoformate.  The yellow reaction solution was refluxed under an 
atmosphere of argon for 48 hours; during the course of the reaction a color change 
from light yellow to red was noted.  Upon cooling, the reaction was quenched by the 
addition of 3 ml of Et3N.  The reaction mixture was diluted with water and extracted 
into EtOAc (3 x 50 ml).  The combined organic layers were dried over MgSO4, 
filtered, and concentrated to afford a brown oil.  Purification by column 
chromatography (35% EtOAc/Hexanes, Rf 0.25) afforded 470 mg (56%) of the 
desired product as a yellow oil.  1H NMR (CDCl3) δ 1.24, (s, 3H), 1.34 (s, 3H), 3.27 
(s, 6H), 4.47– 4.56 (m, 2H), 4.94 (m, 1H), 5.10-5.21 (m, 3H), 6.37-6.41 (m, 2H), 7.30-
7.34 (m, 5).  13C NMR (CDCl3) δ 1.41, 16.3, 18.6, 51.3, 53.3, 68.7, 71.5, 72.1, 72.6, 
77.1, 102.5, 113.5, 128.5, 128.8, 129.0, 129.9, 131.1, 135.9, 158.2.  IR (CCl4) 3064 
(w), 3033 (w), 2994 (m), 2944 (m), 2831 (w), 2365 (w), 2342 (w), 1755 (s), 1717 (s), 
1456 (m), 1398 (m), 1371 (m), 1243 (s) cm-1.  (EI) m/z 391 (5), 302 (7), 116 (8), 91 
N
O
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O
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(100) 89 (72), 43 (7).  HRMS (EI) calcd for C20H25NO7 (M + H)+ 391.1631, found 
391.1631.   
 
To 40 mg (0.102 mmol) of 116  in 4 ml of acetonitrile and 200 µl of 
deionized water was added 7.70 mg of NaBH4 and 5.50 mg of 
Mo(CO)6.  The reaction was heated at reflux for 24 hours.  Upon 
cooling the crude reaction mixture was diluted with EtOAc (20 ml), filtered through a 
pad of celite, and the solvent removed in vacuo.  Purification by column 
chromatography (35% EtOAc/Hexanes, Rf 0.5) afforded 25 mg (62%) of a white 
solid.  Recrystallization from EtOAc/Hexanes afforded colorless cubic crystals (m.p. 
= 117-118 °C) suitable for x-ray crystallographic analysis.  1H NMR (CDCl3) δ 1.34-
1.40 (m, 6H),, 3.60 (br s, 1H), 3.29 (s, 6H), 4.24 (s, 2H), 4.29 –4.32 (m, 1H), 4.41 (br 
s, 1H), 5.10 (s, 2H),  5.20 (s, 1H), 5.72 –5.75 (dt, J = 10 Hz, J=2 Hz, 1H), 5.87 –5.89 
(d, J = 10 Hz, 1H), 7.31 – 7.35 (m, 5H).  IR (CCl4) 3619 (m), 3441 (m), 3029 (w), 
2990 (m), 2944 (m), 2835 (m), 1736 (s), 1507 (s), 1450 (m), 1371 (m), 1243 (m), 
1216 (m), 1130 (m), 1107 (w) cm-1.  
OH
NHCO2CH2Ph
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